Stocks and Investing
by (remove) : Carey Macrury
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Carey Macrury
RSS • JSON • XML • CSV

Carey Macrury Maintained (APTO) at Strong Buy with Decreased Target to $120 on, Mar 27th, 2023


Published on 2024-10-28 02:26:11 - WOPRAI, Carey Macrury
  Print publication without navigation


Carey Macrury of Canaccord Genuity, Maintained "Aptose Biosciences Inc." (APTO) at Strong Buy with Decreased Target from $195 to $120 on, Mar 27th, 2023.

Carey has made no other calls on APTO in the last 4 months.



There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Carey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Carey

  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $75 on, Friday, March 24th, 2023
Contributing Sources